Atlas Trials

Bioavailability Study to Compare OPTINOSE SUMATRIPTAN With IMITREX® in Healthy Subjects

Clinical trial NCT01507610 · COMPLETED

Trial details

NCT number
NCT01507610
Sponsor
Optinose US Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Migraine
Start date
2012-01-01
Primary completion
2012-02-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.